120 related articles for article (PubMed ID: 10533904)
1. The study of PSA gene expression on urogenital cell lines.
Takahashi T; Hoshi S; Satoh M; Kaneda T; Suzuki KI; Nakagawara KI; Orikasa S
Int J Urol; 1999 Oct; 6(10):526-31. PubMed ID: 10533904
[TBL] [Abstract][Full Text] [Related]
2. [Detection of PSA mRNA from the peripheral blood and pelvic lymph nodes in patients with prostatic cancer by means of reverse transcription-polymerase chain reaction (RT-PCR)].
Mao H; Hoshi S; Takahashi T; Kaneda T; Wang J; Suzuki K; Orikasa S
Nihon Hinyokika Gakkai Zasshi; 1998 Jun; 89(6):596-603. PubMed ID: 9666686
[TBL] [Abstract][Full Text] [Related]
3. Molecular staging of prostate cancer: comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer.
Okegawa T; Yoshioka J; Morita R; Nutahara K; Tsukada Y; Higashihara E
Int J Urol; 1998 Jul; 5(4):349-56. PubMed ID: 9712443
[TBL] [Abstract][Full Text] [Related]
4. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay detection of prostate-specific antigen messenger ribonucleic acid in prostate cancer.
Hoshi S; Kobayashi S; Takahashi T; Suzuki KI; Kawamura S; Satoh M; Chiba Y; Orikasa S
Urology; 1999 Jan; 53(1):228-35. PubMed ID: 9886618
[TBL] [Abstract][Full Text] [Related]
6. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C
Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386
[TBL] [Abstract][Full Text] [Related]
7. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
Gomella LG; Raj GV; Moreno JG
J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
[TBL] [Abstract][Full Text] [Related]
9. [RT-PCR assay for detecting PSA mRNA in peripheral blood of prostate cancer patients].
Okubo Y; Ito T
Hinyokika Kiyo; 1999 Jan; 45(1):25-30. PubMed ID: 10086262
[TBL] [Abstract][Full Text] [Related]
10. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
[TBL] [Abstract][Full Text] [Related]
11. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.
Gao CL; Maheshwari S; Dean RC; Tatum L; Mooneyhan R; Connelly RR; McLeod DG; Srivastava S; Moul JW
Urology; 1999 Apr; 53(4):714-21. PubMed ID: 10197846
[TBL] [Abstract][Full Text] [Related]
12. Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using "Light-Cycler"-based quantitative real-time polymerase chain reaction.
Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
Urology; 2001 Nov; 58(5):815-20. PubMed ID: 11711374
[TBL] [Abstract][Full Text] [Related]
13. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
[TBL] [Abstract][Full Text] [Related]
14. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.
Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A
J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538
[TBL] [Abstract][Full Text] [Related]
15. Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen.
Cama C; Olsson CA; Raffo AJ; Perlman H; Buttyan R; O'Toole K; McMahon D; Benson MC; Katz AE
J Urol; 1995 May; 153(5):1373-8. PubMed ID: 7536252
[TBL] [Abstract][Full Text] [Related]
16. Can the reverse transcriptase-polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen improve staging and predict biochemical recurrence?
Adsan O; Cecchini MG; Bisoffi M; Wetterwald A; Klima I; Danuser HJ; Studer UE; Thalmann GN
BJU Int; 2002 Oct; 90(6):579-85. PubMed ID: 12230621
[TBL] [Abstract][Full Text] [Related]
17. Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: value for the staging of prostate cancer.
Hara N; Kasahara T; Kawasaki T; Bilim V; Obara K; Takahashi K; Tomita Y
Clin Cancer Res; 2002 Jun; 8(6):1794-9. PubMed ID: 12060619
[TBL] [Abstract][Full Text] [Related]
18. [Detection of prostate-specific antigen mRNA in preoperative peripheral blood of patients with prostate cancer: relationship to pathological parameters of the surgical specimens].
Iinuma M; Sato K; Ogawa O; Sasaki R; Kato T
Nihon Hinyokika Gakkai Zasshi; 1999 May; 90(5):548-56. PubMed ID: 10386054
[TBL] [Abstract][Full Text] [Related]
19. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells.
Schamhart D; Swinnen J; Kurth KH; Westerhof A; Kusters R; Borchers H; Sternberg C
Clin Chem; 2003 Sep; 49(9):1458-66. PubMed ID: 12928226
[TBL] [Abstract][Full Text] [Related]
20. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay.
Katz AE; Olsson CA; Raffo AJ; Cama C; Perlman H; Seaman E; O'Toole KM; McMahon D; Benson MC; Buttyan R
Urology; 1994 Jun; 43(6):765-75. PubMed ID: 7515202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]